DETAILED PATIENT PACKAGE INSERT
This product (like all oral contraceptives) is
intended to prevent pregnancy. It does not protect against HIV infection (AIDS)
and other sexually transmitted diseases.
INTRODUCTION
Any woman who considers using oral contraceptives (the “birth control pill”
or “the pill”) should understand the benefits and risks of using this form of
birth control.
Although oral contraceptives have important advantages over other methods of
contraception, they have certain risks that no other method has, and some of
these risks may continue after you have stopped using the oral contraceptive.
This leaflet will give you much of the information you will need to make this
decision and will also help you determine if you are at risk of developing any
of the serious side effects of the pill. It will tell you how to use Loestrin 24
Fe properly so that it will be as effective as possible. However, this booklet
is not a replacement for a careful discussion between you and your healthcare
provider. You should discuss the information provided in this booklet with your
healthcare provider, both when you first start taking the pill and during your
revisits. You should also follow your healthcare provider’s advice with regard
to regular check-ups while you are on Loestrin 24 Fe.
EFFECTIVENESS OF ORAL CONTRACEPTIVES
Oral contraceptives or “birth control pill” or “the pill” are used to prevent
pregnancy and are more effective than most other nonsurgical methods of birth
control. The chance of becoming pregnant is approximately 1% per year (1
pregnancy per 100 women per year of use) when the pills are taken correctly, and
no pills are missed. Typical failure rates are 5% per year when women who miss
pills are included. The chance of becoming pregnant increases with each missed
"active" hormonal pill during a 28-day cycle.
In comparison, typical failure rates for other methods of birth control
during the first year of use are as follows:
No birth control methods: 85%
Vaginal sponge: 20 to 40%
Cervical cap:
20 to 40%
Spermicides alone: 26%
Periodic abstinence: 25%
Condom
(female): 21%
Diaphragm with spermicides: 20%
Withdrawal: 19%
Condom
(male): 14%
Female sterilization: less than 1%
IUD: less than
1-2%
Injectable progestogen: less than 1%
Male sterilization: less than
1%
Norplant® system: less than 1%
WHO SHOULD NOT TAKE ORAL CONTRACEPTIVES
Cigarette smoking increases the risk of serious
adverse effects on the heart and blood vessels from oral contraceptive use. This
risk increases with age and with the amount of smoking (15 or more cigarettes
per day has been associated with a significantly increased risk) and is quite
marked in women over 35 years of age. Women who use oral contraceptives should
not smoke.
Some women should not use the pill. You should not use the pill
if you have or have ever had any of the following conditions:
- A history of heart attack or stroke
- A history of blood clots in the legs (thrombophlebitis), lungs (pulmonary
embolism), or eyes
- A history of blood clots in the deep veins of your legs
- Chest pain (angina pectoris)
- Known or suspected breast cancer or cancer of the lining of the uterus,
cervix, vagina, or certain hormonally-sensitive cancers
- Unexplained vaginal bleeding (until a diagnosis is reached by your
healthcare provider)
- Yellowing of the whites of the eyes or of the skin (jaundice) during
pregnancy or during previous use of hormonal contraceptives of any type (the
pill, patch, vaginal ring, injection, or implant)
- Liver tumor (benign or cancerous)
- Known or suspected pregnancy
- Heart valve or heart rhythm disorders that may be associated with formation
of blood clots
- Diabetes with complications of the kidneys, eyes, nerves, or blood vessels
- Severe high blood pressure
- Active liver disease with abnormal liver function tests
- Allergy or hypersensitivity to any of the components of Loestrin 24 Fe
- A need for surgery with prolonged bedrest
- Headaches with neurological symptoms
Tell your healthcare provider if you have any of the above conditions. Your
healthcare provider can recommend a safer method of birth control.
OTHER CONSIDERATIONS BEFORE TAKING ORAL CONTRACEPTIVES
Tell your healthcare provider if you have or ever have had:
- Breast nodules, fibrocystic disease of the breast or an abnormal breast
x-ray or mammogram
- Diabetes
- Elevated cholesterol or triglycerides
- High blood pressure
- Migraine or other headaches or epilepsy
- Depression
- Gallbladder, liver, heart, or kidney disease
- Scanty or irregular menstrual periods
Women with any of these conditions should be checked often by their
healthcare provider if they choose to use oral contraceptives.
Talk to your healthcare provider about using Loestrin 24 Fe if you:
- Smoke
- Recently had a baby
- Recently had a miscarriage or abortion
- Are breastfeeding
- Are taking any other medications
RISKS OF TAKING ORAL CONTRACEPTIVES
1. Risk of developing blood clots
Blood clots and blockage of blood vessels are the most serious side effects
of taking oral contraceptives and can cause death or serious disability. In
particular, a clot in the legs can cause thrombophlebitis, and a clot that
travels to the lungs can cause a sudden blocking of the vessel carrying blood to
the lungs. Either of these can cause death or disability. Rarely, clots occur in
the blood vessels of the eye and may cause blindness, double vision, or impaired
vision.
If you take oral contraceptives and need elective surgery, need to stay in
bed for a prolonged illness or injury, or have recently delivered a baby, you
may be at risk of developing blood clots. You should consult your healthcare
provider about stopping oral contraceptives four weeks before surgery and not
taking oral contraceptives for two weeks after surgery or during bed rest. You
should also not take oral contraceptives soon after delivery of a baby. It is
advisable to wait for at least four weeks after delivery if you are not
breastfeeding. If you are breastfeeding, you should wait until you have weaned
your child before using the pill (see the section on breastfeeding in GENERAL
PRECAUTIONS).
The risk of circulatory disease in oral contraceptive users may be higher in
users of high-dose pills (containing 50 micrograms or higher of ethinyl
estradiol) and may be greater with longer duration of oral contraceptive use. In
addition, some of these increased risks may continue for a number of years after
stopping oral contraceptives. The risk of abnormal blood clotting increases with
age in both users and nonusers of oral contraceptives, but the increased risk
from the oral contraceptive appears to be present at all ages. For women aged 20
to 44 it is estimated that about 1 in 2,000 using oral contraceptives will be
hospitalized each year because of abnormal clotting. Among nonusers in the same
age group, about 1 in 20,000 would be hospitalized each year. For oral
contraceptive users in general, it has been estimated that in women between the
ages of 15 and 34 the risk of death due to a circulatory disorder is about 1 in
12,000 per year, whereas for nonusers the rate is about 1 in 50,000 per year. In
the age group 35 to 44, the risk is estimated to be about 1 in 2,500 per year
for oral contraceptive users and about 1 in 10,000 per year for nonusers.
2. Heart attacks and strokes
Oral contraceptives may increase the tendency to develop strokes (stoppage or
rupture of blood vessels in the brain) and angina pectoris and heart attacks
(blockage of blood vessels in the heart). Any of these conditions can cause
death or disability.
Smoking greatly increases the possibility of suffering heart attacks and
strokes. Furthermore, smoking and the use of oral contraceptives greatly
increase the chances of developing and dying of heart disease.
Women with migraine (especially migraine with aura) who take oral
contraceptives also may be at higher risk of stroke.
3. Gallbladder disease
Oral contraceptive users probably have a greater risk than nonusers of having
gallbladder disease, although this risk may be related to pills containing high
doses of estrogens.
4. Liver tumors
In rare cases, oral contraceptives can cause benign but dangerous liver
tumors. These benign liver tumors can rupture and cause fatal internal bleeding.
In addition, a possible, but not definite, association has been found with the
pill and liver cancers in two studies, in which a few women who developed these
very rare cancers were found to have used oral contraceptives for long periods.
However, liver cancers in general are extremely rare, and the chance of
developing liver cancer from using the pill is thus even rarer.
5. Cancer of the breast and reproductive organs
Breast cancer has been diagnosed slightly more often in women who use the
pill than in women of the same age who do not use the pill. This small increase
in the number of breast cancer diagnoses gradually disappears during the 10
years after stopping use of the pill. It is not known whether the difference is
caused by the pill. It may be that women taking the pill are examined more
often, so that breast cancer is more likely to be detected. You should have
regular breast examinations by a healthcare provider and examine your own
breasts monthly. Tell your healthcare provider if you have a family history of
breast cancer or if you have had breast nodules or an abnormal mammogram.
Women who currently have or have had breast cancer should not use oral
contraceptives because breast cancer is usually a hormone-sensitive tumor.
Some studies have found an increase in the incidence of cancer or
precancerous lesions of the cervix in women who use oral contraceptives.
However, this finding may be related to factors other than the use of oral
contraceptives. There is insufficient evidence to rule out the possibility that
the pill may cause such cancers.
6. Lipid metabolism and inflammation of the pancreas
In patients with inherited defects of lipid metabolism, there have been
reports of significant elevations of plasma triglycerides during estrogen
therapy. This has led to pancreatitis in some cases.
ESTIMATED RISK OF DEATH FROM A BIRTH CONTROL METHOD OR
PREGNANCY
All methods of birth control and pregnancy are associated with a risk of
developing certain diseases which may lead to disability or death. An estimate
of the number of deaths associated with different methods of birth control and
pregnancy has been calculated and is shown in the following table.
ANNUAL NUMBER OF BIRTH-RELATED OR METHOD-RELATED DEATHS ASSOCIATED WITH CONTROL OF FERTILITY PER 100,000 NONSTERILE WOMEN, BY FERTILITY CONTROL METHOD ACCORDING TO AGE
|
|
| AGE
|
|
|
|
Method of control and outcome
| 15-19
| 20-24
| 25-29
| 30-34
| 35-39
| 40-44
|
| No fertility control methods*
| 7.0
| 7.4
| 9.1
| 14.8
| 25.7
| 28.2
|
Oral contraceptives nonsmoker†
| 0.3
| 0.5
| 0.9
| 1.9
| 13.8
| 31.6
|
Oral contraceptives smoker†
| 2.2
| 3.4
| 6.6
| 13.5
| 51.1
| 117.2
|
| IUD†
| 0.8
| 0.8
| 1.0
| 1.0
| 1.4
| 1.4
|
| Condom*
| 1.1
| 1.6
| 0.7
| 0.2
| 0.3
| 0.4
|
| Diaphragm/spermicide*
| 1.9
| 1.2
| 1.2
| 1.3
| 2.2
| 2.8
|
| Periodic abstinence*
| 2.5
| 1.6
| 1.6
| 1.7
| 2.9
| 3.6
|
* Deaths are birth related
† Deaths are method related
In the above table, the risk of death from any birth control method is less
than the risk of childbirth, except for oral contraceptive users over the age of
35 who smoke and pill users over the age of 40 even if they do not smoke. It can
be seen in the table that for women aged 15 to 39, the risk of death was highest
with pregnancy (7 to 26 deaths per 100,000 women, depending on age). Among pill
users who do not smoke, the risk of death was always lower than that associated
with pregnancy for any age group less than 40. Over the age of 40, the risk
increases to 32 deaths per 100,000 women, compared to 28 deaths associated with
pregnancy in that age group. However, for pill users who smoke and are over the
age of 35, the estimated number of deaths exceeds those associated with
pregnancy. If a woman is over the age of 40 and smokes, her estimated risk of
death is four times higher (117/100,000 women) than the estimated risk
associated with pregnancy (28/100,000 women) in that age group.
The suggestion that women over 40 who don't smoke should not take oral
contraceptives is based on information from older high-dose pills. An Advisory
Committee of the FDA discussed this issue in 1989 and recommended that the
benefits of oral contraceptive use by healthy, nonsmoking women over 40 years of
age may outweigh the possible risks. Older women, as all women who take oral
contraceptives, should take an oral contraceptive which contains the least
amount of estrogen and progestin that is compatible with the individual patient
needs.
WARNING SIGNALS
If any of these adverse conditions occur while you are taking oral
contraceptives, call your healthcare provider immediately:
- Sharp chest pain, coughing of blood, or sudden shortness of breath
(indicating a possible clot in the lung)
- Pain in the calf (indicating a possible clot in the leg)
- Crushing chest pain or heaviness in the chest (indicating a possible heart
attack)
- Sudden severe headache or vomiting, dizziness or fainting, disturbances of
vision or speech, weakness, or numbness in an arm or leg (indicating a possible
stroke)
- Sudden partial or complete loss of vision (indicating a possible clot in the
eye)
- Breast lumps (indicating possible breast cancer or fibrocystic disease of
the breast; ask your healthcare provider to show you how to examine your
breasts)
- Severe pain or tenderness in the stomach area (possibly indicating a
ruptured liver tumor)
- Difficulty in sleeping, weakness, lack of energy, fatigue, or change in mood
(possibly indicating severe depression)
- Jaundice or a yellowing of the skin or eyeballs, accompanied frequently by
fever, fatigue, loss of appetite, dark-colored urine, or light-colored bowel
movements (indicating possible liver problems)
SIDE EFFECTS OF ORAL CONTRACEPTIVES
In addition to the risks and more serious side effects discussed above (see
RISKS OF TAKING ORAL CONTRACEPTIVES, ESTIMATED RISK OF DEATH
FROM A BIRTH CONTROL METHOD OR PREGNANCY and WARNING
SIGNALS sections), the following may also occur:
1. Irregular vaginal bleeding
Irregular vaginal bleeding or spotting may occur while you are taking
Loestrin 24 Fe Irregular bleeding may vary from slight staining between
menstrual periods to breakthrough bleeding which is a flow much like a regular
period. Irregular bleeding occurs most often during the first few months of oral
contraceptive use, but may also occur after you have been taking the pill for
some time. Such bleeding may be temporary and usually does not indicate any
serious problems. It is important to continue taking your pills on schedule. If
the bleeding occurs in more than one cycle or lasts for more than a few days,
talk to your healthcare provider.
2. Contact lenses
If you wear contact lenses and notice a change in vision or an inability to
wear your lenses, contact your healthcare provider.
3. Fluid retention or raised blood pressure
Oral contraceptives may cause edema (fluid retention) with swelling of the
fingers or ankles and may raise your blood pressure. If you experience fluid
retention, contact your healthcare provider.
4. Melasma
A spotty darkening of the skin is possible, particularly of the face. The
darkening may persist after stopping the pill.
5. Other side effects
Other side effects may include nausea and vomiting, change in appetite,
breast tenderness, headache, nervousness, depression, dizziness, loss of scalp
hair, rash, vaginal infections, and allergic reactions.
If any of these side effects bother you, call your healthcare provider.
GENERAL PRECAUTIONS
1. Missed periods and use of oral contraceptives before or
during early pregnancy
There may be times when you may not menstruate regularly after you have
completed taking a cycle of pills. If you have taken your pills regularly and
miss one menstrual period, continue taking your pills for the next cycle but be
sure to inform your healthcare provider. If you have not taken the pills daily
as instructed and missed a menstrual period, or if you missed two consecutive
menstrual periods, you may be pregnant. Check with your healthcare provider
immediately to determine whether you are pregnant. Stop taking Loestrin 24 Fe if
you are pregnant.
There is no conclusive evidence that oral contraceptive use is associated
with an increase in birth defects when taken inadvertently during early
pregnancy. Previously, a few studies had reported that oral contraceptives might
be associated with birth defects but these studies have not been confirmed.
Nevertheless, oral contraceptives should not be used during pregnancy. You
should check with your healthcare provider about risks to your unborn child of
any medication taken during pregnancy.
2. While breastfeeding
If you are breastfeeding, consult your healthcare provider before starting
oral contraceptives. Some of the drug will be passed on to the child in the
milk. A few adverse effects on the child have been reported, including yellowing
of the skin (jaundice) and breast enlargement. In addition, oral contraceptives
may decrease the amount and quality of your milk. If possible, do not use oral
contraceptives while breastfeeding. You should use another method of
contraception since breastfeeding provides only partial protection from becoming
pregnant, and this partial protection decreases significantly as you breastfeed
for longer periods of time. You should consider starting oral contraceptives
only after you have weaned your child completely.
3. Laboratory tests
If you are scheduled for any laboratory tests, tell your healthcare provider
you are taking birth control pills. Certain blood tests may be affected by birth
control pills.
4. Drug interactions
Certain drugs may interact with birth control pills to make them less
effective in preventing pregnancy or cause an increase in breakthrough bleeding.
Such drugs include rifampin, drugs used for epilepsy such as barbiturates (for
example, phenobarbital), carbamazepine (Tegretol® is one
brand of this drug), and phenytoin (Dilantin® is one
brand of this drug), primidone (Mysoline®), topiramate
(Topamax®), phenylbutazone (Butazolidin® is one brand), some drugs used for HIV such as ritonavir
(Norvir®), modafinil (Provigil®)
and possibly certain antibiotics (such as ampicillin and other penicillins, and
tetracyclines). Pregnancies and breakthrough bleeding have been reported by
users of combined hormonal contraceptives who also used some form of the herbal
supplement St. John’s Wort. You may need to use a non-hormonal method of
contraception during any cycle in which you take drugs that can make oral
contraceptives less effective. Be sure to tell your healthcare provider if you
are taking or start taking any other medications, including nonprescription
products or herbal products while taking birth control pills.
You may be at higher risk of a specific type of liver dysfunction if you take
troleandomycin (Tao® capsules) and oral contraceptives at
the same time.
5. Sexually transmitted diseases
This product (like all oral contraceptives) is intended to prevent pregnancy.
It does not protect against transmission of HIV (AIDS) and other sexually
transmitted diseases such as Chlamydia, genital herpes, genital warts,
gonorrhea, hepatitis B, and syphilis.